Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal
NCT ID: NCT05050825
Last Updated: 2021-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
470 participants
INTERVENTIONAL
2021-05-03
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CDSA strategy
Children and adolescents presenting with non-severe acute febrile illness or diarrhea managed by healthcare workers trained on the CDSA strategy
Patient clinical management based on the CDSA strategy
The CDSA strategy is a combination of point of care tests (rapid diagnostic tests targeting malaria, dengue fever and streptococcus group a sore through) and a mHealth tool that provides patient management recommendations, including treatment, based on an algorithm integrating patient clinical signs and symptoms, history and diagnostic test results.
Routine practice
Children and adolescents presenting with non-severe acute febrile illness or diarrhea managed by healthcare workers according to routine practice at the health facility
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient clinical management based on the CDSA strategy
The CDSA strategy is a combination of point of care tests (rapid diagnostic tests targeting malaria, dengue fever and streptococcus group a sore through) and a mHealth tool that provides patient management recommendations, including treatment, based on an algorithm integrating patient clinical signs and symptoms, history and diagnostic test results.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ongoing fever will be defined objectively or as a reported fever, defined as : axillary temperature ≥37.5°C or tympanic, oral or rectal temperature ≥38.0°C; and fever duration ≤ 10 days
* ongoing diarrhea will be defined as at least 3 abnormal stools during the last 24hrs
* First consultation for the current illness
* Feasibility of contact between the patient (or his/her designated relative) and the study team at day 3 and day 7
* Written informed consent by the caretaker/legally acceptable representative
Exclusion Criteria
* Age ≥ 15 years
* Clinical status requiring immediate transfer to an appropriate care facility/ severe illness
6 Months
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Pasteur de Dakar
OTHER
Ministry of Health, Senegal
OTHER_GOV
Foundation for Innovative New Diagnostics, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabien Taieb, MD
Role: PRINCIPAL_INVESTIGATOR
Institut Pasteur de Dakar
Aliou Barry, MD
Role: PRINCIPAL_INVESTIGATOR
Institut Pasteur de Dakar
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PS Ndiaye-Fatick
Fatick, , Senegal
PS Kedougou-Dalaba
Kédougou, , Senegal
PS Mbour-Toucouleur
Mbour, , Senegal
PS Pont-Tambacounda
Tambacounda, , Senegal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aliou Barry, MD
Role: primary
Aliou Barry, MD
Role: primary
Aliou Barry, MD
Role: primary
Aliou Barry, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FE007
Identifier Type: -
Identifier Source: org_study_id